Pulmonary circulation and pulmonary hypertension

Endothelial Cells in Health and Disease

Volumn , Issue , 2005, Pages 417-438

  Stevens, Troy ^a   Kasper, Michael ^b   Cool, Carlyne ^c   Voelkel, Norbert ^c  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85048262809     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (52)

1. Hogg DS, McMurray G, Kozlowski RZ. Endothelial cells freshly isolated from small pulmonary arteries of the rat possess multiple distinct k+ current profiles. Lung 2002; 180: 203-214.
2. Kasper M, Schuh D, Muller M. Immunohistochemical localization of the beta subunit of prolyl 4-hydroxylase in human alveolar epithelial cells. Acta Histochem 1994; 96: 309-313.
3. Horvat R, Hovorka A, Dekan G, Poczewski H, Kerjaschki D. Endothelial cell membranes contain podocalyxin-the major sialoprotein of visceral glomerular epithelial cells. J Cell Biol 1986; 102: 484-491.
4. Nielsen S, Smith BL, Christensen EI, Agre P. Distribution of the aquaporin CHIP in secretory and resorptive epithelia and capillary endothelia. Proc Natl Acad Sci USA 1993; 90: 7275-7279.
5. Stenmark KR, Gebb SA. Lung vascular development: breathing new life into an old problem. Am J Respir Cell Mol Biol 2003; 28: 133-137.
6. Jablonka E, Lamb MJ. The changing concept of epigenetics. Ann N Y Acad Sci 2002; 981: 82-96.
7. deMello DE, Sawyer D, Galvin N, Reid LM. Early fetal development of lung vasculature. Am J Respir Cell Mol Biol 1997; 16: 568-581.
8. King J, Weathington T, Creighton J, Wu S, McDonald F, Stevens T. Structural and functional characteristics of lung macro- and microvascular endothelial cell phenotypes. Microvasc Res 2004; 67: 139-151.
9. Al-Mehdi A, Song C, Haroon A, Stevens T. Fluorescence microanatomy of pulmonary vessels in the rat and mouse. Submitted.
10. 2+ and permeability. Am J Physiol 1998; 274: L810-L819.
11. Cioffi DL, Moore TM, Schaack J, Creighton JR, Cooper DM, Stevens T. Dominant regulation of interendothelial cell gap formation by calcium-inhibited type 6 adenylyl cyclase. J Cell Biol 2002; 157: 1267-1278.
12. 2+-inhibited adenylyl cyclase and phosphodiesterase activities. Am J Physiol Lung Cell Mol Physiol 2003; 284: L100-L107.
13. Stevens T, Creighton J, Thompson WJ. Control of cAMP in lung endothelial cell phenotypes. Implications for control of barrier function. Am J Physiol 1999; 277: L119-L126.
14. Reynolds PD, Strada SJ, Thompson WJ. Cyclic GMP accumulation in pulmonary microvascular endothelial cells measured by intact cell prelabeling. Life Sci 1997; 60: 909-918.
15. Grishko V, Solomon M, Wilson GL, Ledoux SP, Gillespie MN. Oxygen radical-induced mitochondrial DNA damage and repair in pulmonary vascular endothelial cell phenotypes. Am J Physiol Lung Cell Mol Physiol 2001; 280: L1300-L1308.
16. King J, Durcova I, Sviridov D, Thakur S, Ying F, Stevens T, Ofori-Acquah S. Essential role of CD166=ALCAM in endothelial cell barrier function. Submitted.
17. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106: 1311-1319.
18. Cool CD, Kennedy D, Voelkel NF, Tuder RM. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol 1997; 28: 434-442.
19. Cool CD, Voelkel NF, Loyd J, Tuder RM. Analysis of vascular lesions in familial primary pulmonary hypertension (FPPH): insights into the endothelial cell and the common denominator of a morphologically heterogeneous disorder. Am J Respir Crit Care Med 1997; 155: A628.
20. Voelkel NF, Tuder RM. Severe pulmonary hypertensive diseases: a perspective. Eur Respir J 1999; 14: 1246-1250.
21. Higenbottam TW, Laude EA. Endothelial dysfunction providing the basis for the treatment of pulmonary hypertension: Giles F. Filley lecture. Chest 1998; 114: 72S-79S.
22. Cool CD, Wood K, Voekel NF. Transdifferentiation of endothelial cells in primary pulmonary hypertension. Am J Respir Crit Care Med 2003; 167: A844.
23. Schwarz MI, King TE Jr. Interstitial Lung Disease. 3rd ed. Hamilton, Ont., Canada: B.C. Decker Inc, 1998.
24. Cool CD, Rai PR, Yeager ME, Serls AE, Bull TM, Brown KK, Routes JM, Tuder RM, Voelkel NF. Human Herpes Virus 8 (HHV-8) expression in primary pulmonary hypertension. N Engl. J. Med 2003; 549: 1113-22.
25. Voelkel NF. Drug-induced pulmonary hypertension: must history repeat itself? Pulm Pharmacol 1996; 9: 67-68.
26. Tuder RM, Radisavljevic Z, Shroyer KR, Polak JM, Voelkel NF. Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension. Am J Respir Crit Care Med 1998; 158: 1999-2001.
27. Ameshima S, Golpon H, Cool CD, Chan D, Vandivier RW, Gardai SJ, Wick M, Nemenoff RA, Geraci MW, Voelkel NF. Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ Res 2003; 92: 1162-1169.
28. Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 1996; 98: 785-792.
29. Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994; 144: 275-285.
30. Tuder RM, Chacon M, Alger L, Wang J, Taraseviciene-Stewart L, Kasahara Y, Cool CD, Bishop AE, Geraci M, Semenza GL, Yacoub M, Polak JM, Voelkel NF. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 2001; 195: 367-374.
31. Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc MG, Waltenberger J, Voelkel NF, Tuder RM. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 2001; 15: 427-438.
32. Cool CD, Stewart JS, Werahera P, Miller GJ, Williams RL, Voelkel NF, Tuder RM. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 1999; 155: 411-419.
33. Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 2001; 88: E2-E11.
34. Bais C, Van Geelen A, Eroles P, Mutlu A, Chiozzini C, Dias S, Silverstein RL, Rafii S, Mesri EA. Kaposi’s sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2= KDR. Cancer Cell 2003; 3: 131-143.
35. Ulger H, Karabulut AK, Pratten, MK. Labelling of rat endothelial cells with antibodies to vWF, RECA-1, PECAM-1, ICAM-1, OX-43 and ZO-1. Anat Histol Embryol 2002; 31: 31-35.
36. Ko YS, Yeh HI, Rothery S, Dupont E, Coppen SR, Severs NJ. Connexin make-up of endothelial gap junctions in the rat pulmonary artery as revealed by immunoconfocal microscopy and triple-label immunogold electron microscopy. J Histochem Cytochem 1999; 47: 683-692.
37. Feuerhake F, Fuchsl G, Bals R, Welsch U. Expression of inducible cell adhesion molecules in the normal human lung: immunohistochemical study of their distribution in pulmonary blood vessels. Histochem Cell Biol 1998; 110: 387-394.
38. Singh B, Tschernig T, van Griensven M, Fieguth A, Pabst R. Expression of vascular adhesion protein-1 in normal and inflamed mice lungs and normal human lungs. Virchows Arch 2003; 442: 491-495.
39. Kawanami O, Jin E, Ghazizadeh M, Fujiwara M, Jiang L, Nagashima M, Shimizu H, Takemura T, Ohaki Y, Arai S, Gomibuchi M, Takeda K, Yu ZX, Ferrans VJ. Heterogeneous distribution of thrombomodulin and von Willebrand factor in endothelial cells in the human pulmonary microvessels. J Nippon Med Sch 2000; 67: 118-125.
40. Muller C, Wingler K, Brigelius-Flohe R. 30UTRs of glutathione peroxidases differentially affect selenium-dependent mRNA stability and selenocysteine incorporation efficiency. Biol Chem 2003; 384: 11-18.
41. Kotton DN, Summer RS, Sun X, Ma BY, Fine A. Stem cell antigen-1 expression in the pulmonary vascular endothelium. Am J Physiol Lung Cell Mol Physiol 2003; 284: L990-L996.
42. Wright L, Tuder RM, Wang J, Cool CD, Lepley RA, Voelkel NF. 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension. Am J Respir Crit Care Med 1998; 157: 219-229.
43. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart J. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993; 328: 1732-1739.
44. Golpon HA, Geraci MW, Moore MD, Miller HL, Miller GJ, Tuder RM, Voelkel NF. HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol 2001; 158: 955-966.
45. Dorfmuller P, Zarka V, Durand-Gasselin I, Monti G, Balabanian K, Garcia G, Capron F, Coulomb-Lhermine A, Marfaing-Koka A, Simonneau G, Emilie D, Humbert M. Chemokine RANTES in severe pulmonary arterial hypertension. Am J Respir Crit Care Med 2002; 165: 534-539.
46. Mason NA, Springall DR, Burke M, Pollock J, Mikhail G, Yacoub MH, Polak JM. High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension. J Pathol 1998; 185: 313-318.
47. Tuder RM, Cool CD, Geraci MW, Wang J, Abman SH, Wright L, Badesch D, Voelkel NF. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med 1999; 159: 1925-1932.
48. Bishop AE, and FM Polak. Pathology of Pulmonury hypertension. In: Lung Transplantation. N.R. Bammer, J M Polak, M. Yacoub, eds. Cambridge University Press 2003, pp. 19-28.
49. Achcar ROD, Voekel NF, Kasper M, Cool CD. Loss of caveolin expression in phenotypically altered endothelial cells and smooth muscle cells in severe pulmonary hypertension. Thorax (under review).
50. Lassalle P, Molet S, Janin A, Heyden JV, Tavernier J, Fiers W, Devos R, Tonnel AB. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 1996; 271: 20458-20464.
51. Tsai JC, Zhang J, Minami T, Voland C, Zhao S, Yi X, Lassalle P, Oettgen P, Aird WC. Cloning and characterization of the human lung endothelial-cell-specific molecule-1 promoter. J Vasc Res 2002; 39: 148-159.
52. Levin EG, Osborn KG, Schleuning WD. Vessel-specific gene expression in the lung: tissue plasminogen activator expression is limited to bronchial arteries and pulmonary vessels of discrete size. Chest 1998; 114: 68S.